Tests

6-Monoacetylmorphine (6-MAM) Confirmation, Urine (U6AMCO)

Amphetamine Confirmation, Urine (UAMPC)

Benzodiazepines Conf, Urine (UBENZC)

Benzoylecgonine Confirmation/Quantitation (BECGO)

Buprenorphine Quant, Urine (UQNTBU)

Cannabinoid Confirmation, Urine (UTHCC)

Cocaine Confirmation, Urine (UCOCC)

Fentanyl and Metabolite, Urine (UFENT)

Methadone Quantitation, Urine (UQMET)

Opiate Confirmation, Urine (OPICON)

Oxycodone Confirmation, Urine (UOXYCC)

Quantitative Pain Panel, Urine (UQNTPP)

Tramadol and Metabolite, Quantitation (TRAQNT)

Build / Reference Range

Specimen Validity pH, Urine:
4.5 – 8.0

Specimen Validity Specific Gravity, Urine:
1.002 – 1.030

Specimen Validity Creatinine, Urine:

18–99 Years (Male):
46.8 – 314.5 mg/dL

18–99 Years (Female):
42.2 – 237.9 mg/dL

Specimen Validity Nitrites, Urine:
≤ 50 mg/L

Specimen Validity Oxidants, Urine:
< 200 mg/L

Specimen Validity Chromate, Urine:
< 50 mg/L

Tests

Opiate Confirmation, Urine (OPICON)

Oxycodone Confirmation, Urine (UOXYCC)

Quantitative Pain Panel, Urine (UQNTPP)

Reference Range

Oxycodone, Urine:
< 10 ng/mL

Specimen Validity Testing (SVT) analytes have a stability of up to 5 days at 2 – 8 °C, as stated in the Instructions for Use (IFU).

Based on the laboratory’s studies, this stability is based on samples that have reached an equilibrium.

• Introduction of oxidants to a urine sample will not be stable until an equilibrium is achieved.
• Time to reach equilibrium will vary dependent on the type and amount of oxidant used as an adulterant.

Diluted

Creatinine: ≥ 2 mg/dL but < 20 mg/dL

Specific Gravity: > 1.0010 but < 1.0030

Substituted

Creatinine: < 2 mg/dL

Specific Gravity: < 1.0010 or ≥ 1.0200

Adulterated

pH: < 3.0 or ≥ 11.0

or Nitrites: ≥ 500 mg/L

or Oxidants: ≥ 200 mg/L

or Chromate: ≥ 50 mg/L